Brendan H. G. Pierce
Papers
1
Total Citations
68
H-Index
1
About
Dr. Brendan H. G. Pierce is a leading head and neck surgical oncologist whose research focuses on optimizing treatment outcomes for patients with oropharyngeal squamous cell carcinoma (OPSCC). His major contributions lie in comparative effectiveness research, particularly evaluating the functional and survival benefits of transoral robotic surgery (TORS) versus chemoradiotherapy. His landmark 2016 study, cited 68 times, demonstrated that TORS-based treatment for OPSCC is associated with significantly lower long-term gastrostomy tube dependence compared to primary chemoradiotherapy, while maintaining comparable survival rates. This work has profoundly influenced clinical decision-making, offering patients a less morbid treatment pathway without compromising oncologic control. Dr. Pierce’s research is widely recognized for its practical impact on reducing treatment-related dysphagia and improving quality of life in head and neck cancer survivors. His findings continue to guide multidisciplinary discussions on personalized treatment selection, making him a pivotal voice in the evolution of organ-preserving surgical approaches.
Research Focus
Key Achievements
Top Papers
- 1